JP Morgan Chase’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $28.5M | Buy |
|
|||||
|
2024
Q1 | $18.6M | Buy |
|
|||||
|
2023
Q4 | $6.65M | Buy |
|
|||||
|
2023
Q3 | $2.12M | Sell |
|
|||||
|
2023
Q2 | $5.13M | Sell |
|
|||||
|
2023
Q1 | $3.97M | Buy |
|
|||||
|
2022
Q4 | $4.13M | Buy |
|
|||||
|
2022
Q3 | $3.69M | Buy |
|
|||||
|
2022
Q2 | $1.56M | Buy |
|
|||||
|
2022
Q1 | $1.69M | Buy |
|
|||||
|
2021
Q4 | $1.39M | Buy |
|
|||||
|
2021
Q3 | $868K | Buy |
|
|||||
|
2021
Q2 | $610K | Buy |
|
|||||
|
2021
Q1 | $36K | Buy |
|